← Leaderboards
Takara Leah Stanley
Massachusetts General Hospital
$7,360,441
Attributed
$13,293,025
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2008–25$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,293,025 · 9
By mechanism
R01$4,031,345 · 1
U24$3,317,535 · 1
P30$2,360,191 · 3
U01$2,197,974 · 1
K23$794,625 · 1
UE5$479,811 · 1
Top collaborators
- Fatima Cody Stanford7 shared
- Kathleen Elizabeth Corey5 shared
- Amy Debra Fleischman4 shared
- Elvira Marie Isganaitis4 shared
- Natalia E. Morone4 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Eng H. Lo$32,456,318
- Fatima Cody Stanford$1,345,751
- Kathleen Elizabeth Corey$4,109,943
- Iain A. Drummond$18,307,587
- Matthew G. Nayor$6,618,481
Others in their field
Top investigators on “Obesity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S. Currier · University Of California Los Angeles$139,907,800
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
ObesityAwardCollaborationsSuccessResearch PersonnelMentorsCommunitiesRecruitAreaGrantUnited States National Institutes Of HealthCareer DevelopmentProgramsFundingLeadershipAffectNutritionCareerLeadApplications GrantsMentorshipMetabolicSomatotropinFatty Acid Glycerol Esters
Grant awards (33)
Understanding, Predicting and Preventing Type 2 Diabetes in Youth, Boston Clinical Center (UPP Study)$994,789
U01 · FY2025 · DK
Creating Opportunities for Unparalleled Researchers to Achieve Growth and Excellence (COURAGE)$810,528
U24 · FY2025 · DK · contact PI
Pilot and Feasibility Core$246,078
P30 · FY2025 · DK · contact PI
Accelerating Research Advancement for Early Career Investigators in Academia$159,937
UE5 · FY2025 · DK
Creating Opportunities for Underrepresented Researchers to Achieve Growth and Excellence (COURAGE)$919,912
U24 · FY2024 · DK · contact PI
Understanding, Predicting and Preventing Type 2 Diabetes in Youth, Boston Clinical Center (UPP Study)$838,919
U01 · FY2024 · DK
Pilot and Feasibility Core$246,078
P30 · FY2024 · DK · contact PI
Understanding, Predicting and Preventing Type 2 Diabetes in Youth, Boston Clinical Center (UPP Study)$197,449
U01 · FY2024 · DK
Accelerating Research Advancement for Investigators Underrepresented in Academia$159,937
UE5 · FY2024 · DK
Creating Opportunities for Underrepresented Researchers to Achieve Growth and Excellence (COURAGE)$964,290
U24 · FY2023 · DK · contact PI
Pilot and Feasibility Core$246,078
P30 · FY2023 · DK · contact PI
Understanding, Predicting and Preventing Type 2 Diabetes in Youth, Boston Clinical Center (UPP Study)$166,817
U01 · FY2023 · DK
Accelerating Research Advancement for Investigators Underrepresented in Academia$159,937
UE5 · FY2023 · DK
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk$807,629
R01 · FY2022 · DK · contact PI
Creating Opportunities for Underrepresented Researchers to Achieve Growth and Excellence (COURAGE)$622,805
U24 · FY2022 · DK · contact PI
Pilot and Feasibility Core$246,078
P30 · FY2022 · DK · contact PI
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk$807,629
R01 · FY2021 · DK · contact PI
Pilot and Feasibility Program$249,455
P30 · FY2021 · DK · contact PI
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk$807,629
R01 · FY2020 · DK · contact PI
Pilot and Feasibility Program$249,455
P30 · FY2020 · DK · contact PI
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk$808,114
R01 · FY2019 · DK · contact PI
Pilot and Feasibility Program$249,455
P30 · FY2019 · DK · contact PI
Pilot and Feasibility Program$128,604
P30 · FY2019 · DK · contact PI
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk$800,344
R01 · FY2018 · DK · contact PI
Pilot and Feasibility Program$249,455
P30 · FY2018 · DK · contact PI
Pilot and Feasibility Program$249,455
P30 · FY2017 · DK · contact PI
Augmenting Pulsatile Growth Hormone: Metabolic Effects in HIV-Infection$158,917
K23 · FY2014 · DK · contact PI
Augmenting Pulsatile Growth Hormone: Metabolic Effects in HIV-Infection$158,919
K23 · FY2013 · DK · contact PI
Augmenting Pulsatile Growth Hormone: Metabolic Effects in HIV-Infection$158,920
K23 · FY2012 · DK · contact PI
Augmenting Pulsatile Growth Hormone: Metabolic Effects in HIV-Infection$158,920
K23 · FY2011 · DK · contact PI
Metabolic Effects of Augmenting Pulsatile Growth Hormone Secretion in HIV-Infecti$158,949
K23 · FY2010 · DK · contact PI
Growth Hormone Releasing Hormone in Patients with HIV Lipodystrophy$56,702
F32 · FY2009 · DK · contact PI
Growth Hormone Releasing Hormone in Patients with HIV Lipodystrophy$54,842
F32 · FY2008 · DK · contact PI